"Global Cytomegalovirus Retinitis Market 2014-2018" Published

Cytomegalovirus retinitis is a viral eye inflammation of the retina. The causative organism of this disease is cytomegalovirus, a herpes virus that attacks the photosensitive cells in the retina. This disease can lead to permanent blindness if left untreated. It affects one eye initially but spreads to the other eye if neglected. The virus is very commonly found in humans but stays dormant. It usually affects a person with weakened immune system such as HIV-positive patients. There are two forms of cytomegalovirus retinitis: indolent form and fulminant form. Some of the common symptoms of cytomegalovirus retinitis are blurred vision, seeing floaters, photophobia, and blind spots.

TechNavio's analysts forecast the Global Cytomegalovirus Retinitis market to grow at a CAGR of 4.50 percent over the period 2013-2018.

Full Report Details at
- http://www.fastmr.com/prod/872322_global_cytomegalovirus_retinitis_market_20142018.aspx?afid=302

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Cytomegalovirus Retinitis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various branded and generic drugs used for the treatment of cytomegalovirus retinitis. Capsules, implants, solutions, and tablets are the four dosage forms of the drugs used for the treatment of cytomegalovirus retinitis.

TechNavio's report, the Global Cytomegalovirus Retinitis market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cytomegalovirus Retinitis market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

* Americas
* APAC
* EMEA

Key Vendors

* F. Hoffmann-La Roche
* Gilead Sciences
* Hospira
* Shire

Other Prominent Vendors

* Auritec Pharmaceuticals
* Chimerix Pharmaceuticals
* Isis Pharmaceuticals
* pSivida
* Sanofi

Market Driver

* Presence of Unmet Needs
* For a full, detailed list, view our report

Market Challenge

* Lack of Approved Treatment Guidelines by the World Health Organization
* For a full, detailed list, view our report

Market Trend

* Increase in Combination Therapies
* For a full, detailed list, view our report

Key Questions Answered in this Report

* What will the market size be in 2018 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013
- Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2013
- Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013
- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2014
- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014